Target Price | €24.55 |
Price | €22.84 |
Potential | 7.47% |
Number of Estimates | 17 |
17 Analysts have issued a price target Commerzbank 2026 . The average Commerzbank target price is €24.55. This is 7.47% higher than the current stock price. The highest price target is €30.00 31.35% , the lowest is €21.50 5.87% . | |
A rating was issued by 19 analysts: 11 Analysts recommend Commerzbank to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Commerzbank stock has an average upside potential 2026 of 7.47% . Most analysts recommend the Commerzbank stock at Purchase. |
13 Analysts have issued a sales forecast Commerzbank 2025 . The average Commerzbank sales estimate is €11.9b . This is 54.02% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €12.5b 51.55% , the lowest is €11.1b 57.25% .
This results in the following potential growth metrics:
2024 | €26.1b | 15.98% |
---|---|---|
2025 | €11.9b | 54.37% |
2026 | €12.7b | 6.48% |
2027 | €13.4b | 5.86% |
2028 | €13.7b | 2.22% |
11 Commerzbank Analysts have issued a net profit forecast 2025. The average Commerzbank net profit estimate is €2.2b . This is 17.11% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.4b 8.89% , the lowest is €1.8b 31.11% .
This results in the following potential growth metrics and future Net Margins:
2024 | €2.4b | 27.61% |
---|---|---|
2025 | €2.2b | 10.33% |
2026 | €3.4b | 56.50% |
2027 | €4.0b | 20.23% |
2028 | €4.9b | 19.84% |
2024 | 9.21% | 10.03% |
---|---|---|
2025 | 18.09% | 96.49% |
2026 | 26.59% | 46.99% |
2027 | 30.20% | 13.58% |
2028 | 35.40% | 17.22% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.08 | 1.87 |
27.61% | 10.10% | |
P/E | 12.25 | |
EV/Sales | 6.47 |
11 Analysts have issued a Commerzbank forecast for earnings per share. The average Commerzbank EPS is €1.87 . This is 16.89% lower than earnings per share in the financial year 2024. The highest EPS forecast is €2.05 8.89% , the lowest is €1.55 31.11% .
This results in the following potential growth metrics and future valuations:
2024 | €2.08 | 27.61% |
---|---|---|
2025 | €1.87 | 10.10% |
2026 | €2.92 | 56.15% |
2027 | €3.51 | 20.21% |
2028 | €4.21 | 19.94% |
Current | 10.16 | 40.33% |
---|---|---|
2025 | 12.25 | 20.57% |
2026 | 7.82 | 36.16% |
2027 | 6.51 | 16.75% |
2028 | 5.43 | 16.59% |
Based on analysts' sales estimates for 2025, the Commerzbank stock is valued at an EV/Sales of 6.47 and an P/S ratio of 2.28 .
This results in the following potential growth metrics and future valuations:
Current | 2.97 | 98.00% |
---|---|---|
2025 | 6.47 | 117.77% |
2026 | 6.07 | 6.09% |
2027 | 5.74 | 5.54% |
2028 | 5.61 | 2.17% |
Current | 1.05 | 43.92% |
---|---|---|
2025 | 2.28 | 117.50% |
2026 | 2.14 | 6.09% |
2027 | 2.02 | 5.54% |
2028 | 1.97 | 2.17% |
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | Mar 30 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 27 2025 |
HSBC |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
WARBURG RESEARCH GMBH |
Buy
➜
Buy
|
Unchanged | Feb 27 2025 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Feb 16 2025 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Jan 05 2025 |
Analyst Rating | Date |
---|---|
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
Mar 30 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 27 2025 |
Unchanged
HSBC:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
WARBURG RESEARCH GMBH:
Buy
➜
Buy
|
Feb 27 2025 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Feb 16 2025 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Jan 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.